Abstract
Variceal injection of the tissue adhesive N-butyl-2-cyanoacrylate (Histoacryl; B. Braun Melsungen AG, Pfieffewiesen, Germany) has become an accepted treatment for acutely bleeding esophagogastric varices.1 Injection of this agent, in combination with conventional sclerotherapy, has been used to improve the initial control of bleeding from huge esophagogastric varices and to prevent recurrent bleeding.2,3 Despite excellent hemostatic efficacy, however, several undesirable effects are reported with gastric variceal injection of N-butyl-2-cyanoacrylate.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
